Kaleido Biosciences Inc. (KLDO)
NASDAQ · Healthcare
Kaleido Biosciences Inc. Revenue 2016–2021
Kaleido Biosciences Inc. annual/quarterly revenue history and growth rate from 2016 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Kaleido Biosciences Inc. revenue for the quarter ending December 31, 2021 was 492000, a 102.47% increase year-over-year.
- Kaleido Biosciences Inc. revenue for the twelve months ending December 31, 2021 was 1.1 M.
- Kaleido Biosciences Inc. annual revenue for 2021 was 1.1 M, a 13.23% increase from 2020.
- Kaleido Biosciences Inc. annual revenue for 2020 was 975000.
- Kaleido Biosciences Inc. annual revenue for 2019 was 0.
- Kaleido Biosciences Inc. annual revenue for 2018 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Kaleido Biosciences Inc. (KLDO) — Frequently Asked Questions
Kaleido Biosciences Inc. (KLDO) is a publicly traded US company. In fiscal 2021 it reported revenue of $1M and net income of -$90M. Explore KLDO's stock price, financial statements, earnings history, margins and key ratios below.
What is the KLDO stock price?
KLDO trades at $0.00.
How much revenue does Kaleido Biosciences Inc. make?
Kaleido Biosciences Inc. reported revenue of $1M in fiscal 2021.
Is KLDO profitable?
In fiscal 2021, Kaleido Biosciences Inc. reported net income of -$90M.